Prescription Bias in the Treatment of Chronic Systolic Heart Failure

Ann Intern Med. 2020 Jan 7;172(1):70-72. doi: 10.7326/M19-0476. Epub 2019 Oct 1.

Authors

Henrike Arfsten¹, Georg Goliasch¹, Noemi Pavo¹, Hanno Ulmer², Martin Hülsmann¹, Thomas Stefenelli³; Austrian Working Group of Heart Failure

Collaborators

Austrian Working Group of Heart Failure:
Guido Strunk, Gerhard Poelzl, Christian Ebner, Friedrich Fruhwald, Claudia Dornaus, Georg Grimm, Hans Altenberger, Gabriele Jakl, Johann Auer, Andreas Winter, Doris Keroe, Hubert Groebne, Lalit Kaltenbach

Affiliations

¹ Medical University of Vienna, Vienna, Austria (H.A., G.G., N.P., M.H.).
² Medical University of Innsbruck, Innsbruck, Austria (H.U.).
³ Donauspital, Vienna, Austria (T.S.).

PMID: 31569211
DOI: 10.7326/M19-0476

No abstract available

Publication types

Letter

MeSH terms

Adrenergic beta-Antagonists / administration & dosage*
Adrenergic beta-Antagonists / therapeutic use
Aged
Angiotensin-Converting Enzyme Inhibitors / administration & dosage
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Bias*
Chronic Disease
Female
Heart Failure, Systolic / drug therapy*
Humans
Male
Middle Aged
Practice Patterns, Physicians'* / statistics & numerical data
Registries / statistics & numerical data

Substances

Adrenergic beta-Antagonists
Angiotensin-Converting Enzyme Inhibitors